SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-22-312718
Filing Date
2022-12-27
Accepted
2022-12-27 17:12:15
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d418283d424b5.htm 424B5 314123
2 GRAPHIC g418283g01a01.jpg GRAPHIC 44025
  Complete submission text file 0001193125-22-312718.txt   376228
Mailing Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Filer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 424B5 | Act: 33 | File No.: 333-256378 | Film No.: 221491009
SIC: 2834 Pharmaceutical Preparations